Litcius/Paper detail

Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020

Ioannis Veliziotis, Alain Roman, Delphine Martiny, Gerlind Schuldt, Marc Claus, Nicolás Dauby, Sigi Van den Wijngaert, Charlotte Martin, Rakan Nasreddine, Claudia Perandones, Romain Mahieu, Corien Swaan, Serge Van Praet, Déborah Konopnicki, Maria Aurora Morales, Denis Malvy, Etienne Stevens, Philippe Dechamps, Erika Vlieghe, Olivier Vandenberg, Stephan Günther, Michèle Gérard

2020Emerging infectious diseases35 citationsDOIOpen Access PDF

Abstract

We report a case of Argentine hemorrhagic fever diagnosed in a woman in Belgium who traveled from a disease-endemic area. Patient management included supportive care and combination therapy with ribavirin and favipiravir. Of 137 potential contacts, including friends, relatives, and healthcare and laboratory workers, none showed development of clinical symptoms of this disease.

Topics & Concepts

FavipiravirRibavirinMedicineDiseaseLassa feverDisease managementIntensive care medicineCrimean–Congo hemorrhagic feverVirologyPediatricsInternal medicineVirusInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)Hepatitis C virusParkinson's diseaseViral Infections and Outbreaks ResearchViral Infections and VectorsHepatitis B Virus Studies